Bishr Al Dabagh, MD
MOHS-Micrographic Surgery · Mooresville, NCNPI 1154565661
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,527 of the $1,907 with a category attached, or 80.1%. 22 manufacturers reported payments, led by Johnson & Johnson at 30.8% of the total.
Across 79 payments — averaging $24.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$588
- AbbVie$196
- Sanofi$159
- Sun Pharmaceutical Industries Inc.$125
- E.r. Squibb & Sons, L.L.C.$108
- Dermavant Sciences, Inc.$104
- plus $627 from 16 others
What the payments were for
- Food & beverage$1,52780%
- Education$38020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $588 |
| AbbVie(2 entities) | 6 | $196 |
| Sanofi | 7 | $159 |
| Sun Pharmaceutical Industries Inc. | 7 | $125 |
| E.r. Squibb & Sons, L.L.C. | 2 | $108 |
| Dermavant Sciences, Inc. | 5 | $104 |
| Lilly USA, LLC | 5 | $84 |
| Organogenesis Inc. | 2 | $74 |
| Convatec Inc. | 3 | $74 |
| Biofrontera Inc. | 4 | $65 |
| Galderma Laboratories, L.p. | 4 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Botanix SB Inc | 2 | $36 |
| Mimedx Group, Inc. | 2 | $33 |
| Pfizer | 1 | $26 |
| Organon | 1 | $22 |
| Novartis | 1 | $21 |
| LEO Pharma Inc. | 1 | $20 |
| Journey Medical Corporation | 1 | $20 |
| Bioventus LLC | 1 | $15 |
| Incyte Corporation | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $13 |
How this compares
$1,907 in reported general payments places this provider in the 60th percentile of 50 mohs-micrographic surgery providers in North Carolina.
See all mohs-micrographic surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 429 | $2,927 |
| Clobetasol Propionate | 66 | $2,741 |
| Cephalexin | 558 | $2,645 |
| Fluorouracil | 37 | $2,563 |
| Ketoconazole | 109 | $2,106 |
| Triamcinolone Acetonide | 101 | $1,310 |
| Metronidazole | 16 | $853 |
| Clindamycin Phosphate | 29 | $662 |
| Clindamycin Hcl | 112 | $471 |
| Hydrocortisone | 34 | $186 |
| Doxycycline Hyclate | 16 | $170 |
| Amoxicillin | 51 | $56 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Mooresville
- Girish MunavalliCharlotte$118K
- Eric ChallgrenRaleigh$47K
- Laura RosenzweigCharlotte$27K
- David LaneCharlotte$14K
- Timothy FlynnCary$12K
- Gregory WilmothRaleigh$8K
- Randall ProctorGreenville$6K
- Steffany ShearerRaleigh$5K
- Sasha HaberleCharlotte$4K
- Euphemia MuCharlotte$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.